The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers - EP3236985

The patent EP3236985 was granted to Immatics Biotechnologies on Sep 7, 2022. The application was filed on Dec 16, 2015 under application number EP15813809A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3236985

IMMATICS BIOTECHNOLOGIES
Application Number
EP15813809A
Filing Date
Dec 16, 2015
Status
Patent Maintained As Amended
Aug 5, 2022
Publication Date
Sep 7, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ADAPTIMMUNEJun 25, 2020MEWBURN ELLISADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTJP4406607B
INTERNATIONAL-SEARCH-REPORTUS2014273275
INTERNATIONAL-SEARCH-REPORTWO0144279
INTERNATIONAL-SEARCH-REPORTWO2004061423
INTERNATIONAL-SEARCH-REPORTWO2013070603
INTERNATIONAL-SEARCH-REPORTWO2014039675
INTERNATIONAL-SEARCH-REPORTWO2014118552
OPPOSITIONWO2008021290
OPPOSITIONWO2010034514

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents